Sulaco, the Bavi scientific story just seems to get stronger over time. We now know what therapies Bavi will help and those it won't. Fortunately, Bavi will help the hot new immunotherapies. This could result in some great results for patients and great results for we long suffering shareholders.
How about some partnering news before Christmas? That's the kind of present we really need.
News 
Market Data 
Discover 
AI
